HCR Wealth Advisors’s Tenax Therapeutics TENX Stock Holding History

HCR Wealth Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10	Closed	-$14K	–	260
2020 Q2	$14K	Buy	+10	New	+$14.7K	﹤0.01%	217

Other funds holding TENX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HCR Wealth Advisors's TENX Position: Q3 2020 in Review

HCR Wealth Advisors sold out of Tenax Therapeutics (TENX) in Q3 2020, closing a stake of 10 shares — an estimated $14K sold.

HCR Wealth Advisors first reported a position in TENX in Q2 2020 and held it in 1 quarter. The position peaked at $14K in Q2 2020. 15 funds tracked by Wall St. Rank hold TENX as of Q3 2020.

HCR Wealth Advisors reported no remaining Tenax Therapeutics position as of Q3 2020 after selling out during the quarter.
HCR Wealth Advisors sold 10 Tenax Therapeutics shares in Q3 2020, an estimated $14K.
HCR Wealth Advisors first reported a position in Tenax Therapeutics in Q2 2020 and held it in 1 quarter.
HCR Wealth Advisors's Tenax Therapeutics position peaked at $14K in Q2 2020.
15 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2020.

Based on HCR Wealth Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.